Drug Information

Drug General Information
Drug ID
D0V4YW
Former ID
DNCL002319
Drug Name
Hepcidin mab
Drug Type
Antibody
Indication Anemia [ICD9: 280-285; ICD10:D50-D64] Phase 1 [523448]
Company
Eli Lilly
Target and Pathway
Target(s) Hepcidin Target Info [544389]
WikiPathways Iron metabolism in placenta
References
Ref 523448ClinicalTrials.gov (NCT01340976) A Phase 1 Study of LY2787106 in Cancer and Anemia. U.S. National Institutes of Health.
Ref 544389The pathophysiology and pharmacology of hepcidin. Trends Pharmacol Sci. 2014 March; 35(3): 155-161.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.